Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
& Larsen, P
Any concerning cognitive symptoms warrant clinical evaluation to exclude other causes, and the risk-benefit balance of continuing GLP-1 therapy should be individually assessed
Depending on medical needs, treatment pathways can include care for endocrinology and metabolic disorders or procedural options for severe obesity
Available from: Lee J, Kim MH, Jang JY, Oh CM
US$ 21.14
US$ 20.61
US$ 27.27
US$ 24.59
US$ 20.19
US$ 21.11
US$ 26.72
US$ 23.36
US$ 24.10
US$ 23.27
